Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Trevian's Move attracts companies back to the challenging Pitäjänmäki area in Helsinki

The Move office property in Helsinki has completed a comprehensive space renovation, strengthened its services, and attracted companies to the challenging Pitäjänmäki office area. Trevian Asset Management is responsible for the development and leasing of Move and started managing the property in the summer of 2022. The property's active development, numerous renovations, and improved transport connections have been critical factors in Move's growth. Long-term cooperation agreements with Compass Group's restaurant services and sports center operator Elixia significantly strengthen services

Finland’s Metaplay releases new game development backend to make it easier for ambitious developers to make mobile games at scale

The SDK, developed for four years by working with top-tier game studios in Helsinki like Metacore, Dodreams, and Nitro, enables games to achieve real scale and keep growing with custom features and live services.Finnish scaleup Metaplay , the company behind the fully customizable backend for game development, has announced the global release of its new Unity-based gaming software development kit (SDK) to enable ambitious developers and studios to make top-tier online mobile games that can scale as they grow.   The Metaplay SDK brings customizable and fully

Tradedoubler reports preliminary results for the fourth quarter of 2023

As a result of a ransomware attack on one of the company's hosting providers TietoEvry, Tradedoubler reports its preliminary unaudited results for the fourth quarter as it cannot be ensured that information has remained confidential.   Currently some of Tradedoubler's internal and financial systems are affected, but no business-related systems. We take the situation very seriously and are in ongoing dialogue with TietoEvry to resolve the matter. We do not expect any major impact on Tradedoubler’s business and the business of our clients and partners.   More information will be

No. 8, 2024 – New amounts to auction of covered mortgage bonds in Nordea Kredit

With the refinancing of Nordea Kredit Realkreditaktieselskab's adjustable rate mortgages (ARMs) as of 1 April 2024 an electronic auction will be held in February 2024.   The ARMs will be refinanced in covered mortgage bonds (SDRO). Nordea Danmark will conduct the auction.   The Auction The auction will be held in the auction market for mortgage bonds at NASDAQ Copenhagen. The Dutch (hidden call) auction principle will be applied, implying that where bids exceed the cut-off price, the full amount will be allocated at the cut-off price. Bids made at the cut-off price may be

Monivent Neo100 was associated with superior performance in a study from King’s College London

The study conducted at King’s College London with the use of Neo100, was published in Archives of Disease in Childhood, Fetal and Neonatal Edition. The manikin study demonstrates that the use of a RFM (respiratory function monitor) was associated with superior performance in mask ventilation with the effect being more pronounced in less experienced resuscitators.The results of the study were presented in the publication “Influence of clinical experience on newborn manikin mask ventilation performance using a respiratory function monitor”. The study was conducted to evaluate whether the

Balco Group acquires Riikku Group Oy and carries out a small targeted share issue

Balco Group AB has today entered into an agreement on and completed the acquisition of all shares in Riikku Group Oy, one of Finland's leading companies in balcony glazing. Access has taken place today. The purchase price is paid partly in cash, partly through a directed new issue of shares in Balco Group to the sellers of Riikku Group Oy. The acquisition, which is the largest Balco Group has completed to date, will be consolidated from 1 January 2024 and is expected to contribute positively to earnings per share during the full year 2024.Through the acquisition, Balco Group establishes a

Zengun Group AB (publ) announces the expiration time for the tender offer in respect of its outstanding bonds

On 17 January 2024, Zengun Group AB (publ) (“Zengun” or the “Company”) announced, in connection with the contemplated issuance of new SEK denominated senior secured sustainability-linked bonds (the “New Bonds”), an invitation to the holders of the Company’s outstanding senior secured bonds with maturity on 19 October 2024 and with ISIN SE0014991220 (the "Outstanding Bonds”) to participate in a tender offer as further described in the tender information document dated 17 January 2024 (the “Tender Information Document”) subject to the terms and conditions set forth in the Tender Information

BLAST Premier and GG.BET agree global esports betting partnership for 2024

World-renowned Counter-Strike tournament series BLAST Premier has announced a global partnership with leading esports betting brand GG.BET.As part of the partnership, GG.BET will be featured across multiple activations, offering BLAST’s audience exciting experiences and integrations to bring fans even closer to the Counter-Strike action. These activations include talent predictions and BLAST.tv Pick ‘Ems, live betting odds broadcast integration, social media giveaways, exclusive content and physical/digital branding across the BLAST Premier tournament series.  GG.BET is an international

Targinta’s CEO to BioStock: “Strong interest in ADCs in 2023”

During 2023, we have witnessed several significant business deals involving Antibody-drug conjugates (ADC), both in preclinical and clinical phase. This signals a continued strong interest in the field. AbbVie made a multi-billion dollar acquisition of ImmunoGen, Merck entered into a development agreement with Daiichi, and Pfizer acquired Seagen for a record amount. Evy Lundgren-Åkerlund, CEO of ADC developer Targinta, shares her analysis.Read the full article at biostock.se : https://www.biostock.se/en/2024/01/targintas-ceo-strong-interest-in-adcs-in-2023/

ITAB signs agreement for delivery of interiors and checkouts to leading fashion chain in Europe

ITAB Group (“ITAB”) has signed an agreement with a leading fashion chain in Europe for the delivery of interiors, checkouts, and dressing rooms for the refurbishment of existing stores and in upcoming new stores. The implementation will begin in February 2024 and the total value of the contract is estimated for approximately MEUR 16 over three years.Together with the customer, a leading fashion chain in Europe, ITAB has developed a tailored solution for the chain’s stores covering the needs of modern consumers as well as improved performance and design of the customer. Under the contract,

Nordea to present its fourth-quarter and full-year results 2023 on 5 February

The report will be published at approximately 07.30 EET (06.30 CET) on Monday 5 February 2024. Webcast at 11.00 EET (10.00 CET) Frank Vang-Jensen, President and Group CEO, will present the results followed by a target update presentation together with Ian Smith, Group CFO. After the presentations a Q&A audio session will be held for investors and analysts with Frank Vang-Jensen, Ian Smith and Ilkka Ottoila, Head of Investor Relations. To join the live webcast, please use the webcast link . In the Q&A session, questions to management can be

Image System's business area RemaSawco receives an order from Moelven Valåsen AB for just over SEK 6.4 million

RemaSawco AB has signed an agreement with Moelven Valåsen AB for the delivery of a new board scanner to the planing mill in the company's sawmill in Valåsen, Karlskoga. The order value amounts to just over SEK 6.4 million.Moelven Valåsen Wood AB has signed an agreement with RemaSawco AB regarding the upgrade of the sawmill's planning mill in Karlskoga. The order includes yet another of RemaSawco's market-leading board scanners, the RS-BoardScannerQ and the application RS-StrengthGrader for strength classification of boards and planks. This order means that Moelven Valåsen is now taking

BioStock: Alligator granted US patent for cancer therapy platform

Through its propriatary Neo-X-Prime platform, Alligator Bioscience has generated ATOR-4066 – a bispecific antibody aimed at boosting immune cells in cancer patients. Now, the company has been granted the first US patent protecting ATOR-4066. BioStock spoke with Alligator’s CEO Søren Bregenholt to better understand the importance of this patent.Read the interview with Søren Bregenholt at biostock.se: Alligator granted US patent for cancer therapy platform - BioStock This is a press release

Paradigm Capital Value Fund (Sicav) holds more than 30 per cent of the shares and votes in Jetpak

This press release is not an offer to acquire shares. This press release is made in accordance with Chapter 3 section 1 of the Swedish Act on Public Takeovers on the Stock Market (2006:451).Paradigm Capital Value Fund (Sicav) B129149 RCS Luxembourg (“Paradigm Capital”) has acquired an additional 734,444 shares in Jetpak Top Holding AB (publ), reg.no. 559081-5337, (“Jetpak”) for a maximum consideration of SEK 79 per share.[1] Through the acquisition, Paradigm Capital has attained a direct and indirect[2][ ]holding of 4,220,795 B shares in Jetpak, corresponding to a holding of approximately

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 18 - 22 JANUARY 2024 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 186/23 and 187/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Invitation to Vår Energi’s Capital Markets Update 2024

Sandnes, Norway, 22 January 2024: Vår Energi ASA (OSE: VAR) is pleased to invite investors, analysts, and other stakeholders to a Capital Markets Update on 13 March 2024 at 14:00 (CET). The event will be held in central Oslo, with the alternative of joining digitally. Further information, including a detailed agenda, will be made available closer to the event date on varenergi.no/en/investor. About Vår Energi Vår Energi is a leading independent upstream oil and gas company on the Norwegian continental shelf (NCS). We are committed to deliver a better future through responsible

Outokumpu’s Shareholders’ Nomination Board gives their proposals to the Annual General Meeting 2024

Outokumpu OyjStock exchange releaseJanuary 22, 2024 at 10.00 am EETOutokumpu’s Shareholders’ Nomination Board gives their proposals to the Annual General Meeting 2024 The Shareholders’ Nomination Board of Outokumpu Oyj proposes to the Annual General Meeting 2024 that the meeting would decide on the composition and remuneration of the Board of Directors as well as the charter of the Shareholders’ Nomination Board as follows: The composition of the Board of Directors The Shareholders’ Nomination Board proposes that the Board of Directors would consist of eight (8) members and

The subscription price for warrants of series TO 6 B has been set at SEK 0.10 per share

Lund, Sweden - Clinical Laserthermia Systems AB ("CLS" or the "Company") hereby announces the subscription price for the exercise of warrants of series TO 6 B, which was issued in connection with the Company's rights issue of units resolved by the extraordinary general meeting on June 8, 2023. The subscription price for warrants of series TO 6 B has been set at SEK 0.10 per share and the exercise period begins tomorrow, January 23, 2024.In connection with the Company's rights issue of units, which was resolved on at the extraordinary general meeting on June 8, 2023, CLS issued 234,582,810

Presentation of Probi’s Year-End Report 2023

Probi’s Year-End Report for 2023 will be published on Friday, 26 January at 8.00 a.m. CET. In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Anita Johansen and CFO Per Lindblad will present and comment on the report. The presentation and presentation material can be obtained via www.probi.com or https://ir.financialhearings.com/probi-q4-report-2023 

Cereno Scientific announces that equity research company Edison initiates coverage of the company

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that equity research company Edison Investment Research has been engaged by Cereno to produce regular, in-depth research on the company. The intention is to raise the visibility of the company and enable investors and stakeholders to develop an improved understanding of the business.Edison's research is read on a free-to-access basis by individuals and institutions across the globe. Edison's coverage of Cereno will be available on the company

Buybacks of shares in ITAB during week 3 2024

During the period between 15 and 19 January 2024, ITAB Shop Concept AB (publ) (”ITAB”) (LEI-code: 2138001H6FCSZBP26351) has repurchased in total 95,780 own ordinary shares (ISIN: SE0015962097) as part of the share buyback program initiated by the Board of Directors in order to optimise the capital structure.The share buybacks form part of the share buyback program in a maximum amount of MSEK 50 that ITAB announced on 28 September 2023. The share buyback program, which runs from 29 September 2023 until 14 May 2024, is being carried out in accordance with the EU Market Abuse Regulation (“MAR”)

Inhalation Sciences signs new partnership with Actarmo Medical: End-to-end offering for respiratory drug development Services

Inhalation Sciences AB (ISAB) has signed a new partnership with fellow European inhalation development service provider Actarmo Medical GmbH based in Germany. The new partnership is expected to enlarge the service scope and offerings to the client pipelines of both companies. ISAB and Actarmo have highly complementary services at either end of the respiratory drug development chain, in the fast-growing inhaled therapeutics market.Inhalation Sciences AB has entered a new partnership with Actarmo Medical GmbH, a respiratory drug development services provider headquartered in Gauting, Germany.

CESSATECH ANNOUNCES THAT MANAGEMENT AND BOARD HAVE EXERCISED ALL THEIR WARRANTS OF SERIES TO2

Copenhagen, Denmark, January 22, 2024 – Cessatech A/S ("Cessatech" or the "Company") announces that all members of the Company’s Senior Management and Board of Directors, including CEO Jes Trygved and Chairman of the Board of Directors, Martin Olin, have exercised all their warrants of Series TO2. In totality, Cessatech’s Senior Management and Board of Directors will subscribe for approximately DKK 1.75 million through the exercise of their TO2 warrants.If all the warrants of series TO2 are exercised, the Company will receive approximately DKK 18.1 million before issuing costs. For the

Cinis Fertilizer has secured deliveries of inputs for production according to plan

Cinis Fertilizer has secured supplies of inputs for the start of production according to plan and for full production during the rest of the year. The delays at the collaboration partner Northvolt will neither affect the company's planned start of production nor the production volumes for 2024, as the company has agreements with complementary suppliers of the input sodium sulfate."In order to ensure planned production volumes throughout the year 2024, we have activated our agreements with existing and new suppliers both in Sweden and internationally. These suppliers of sodium sulfate

There are no items matching the current filter
There are no more items matching the current filter
Back to top